Gates Foun­da­tion, Mas­ter­card, Well­come launch coro­n­avirus treat­ment ac­cel­er­a­tor as out­break deep­ens

A month af­ter an­nounc­ing it was pre­pared to spend $100 mil­lion on R&D ef­forts against the nov­el coro­n­avirus — and with the out­break show­ing no signs of wan­ing — the Bill and Melin­da Gates Foun­da­tion re­vealed where much of that mon­ey would be spent.

The foun­da­tion, Well­come and Mas­ter­card launched the Covid-19 Ther­a­peu­tics Ac­cel­er­a­tor to­day. With $50 mil­lion each from Gates and Well­come and $25 mil­lion from Mas­ter­card, the ac­cel­er­a­tor will sup­port phar­ma­ceu­ti­cal com­pa­nies, biotechs and aca­d­e­m­ic re­searchers hunt­ing for an­tivi­rals that can treat the nov­el coro­n­avirus that has now claimed over 4,000 lives world­wide.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER